{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:33:47Z","timestamp":1791862427753,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.yebeh.2015.04.039","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T14:06:14Z","timestamp":1432562774000},"page":"34-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Assessment of both serum S-100B protein and neuropeptide-Y levels in childhood breath-holding spells"],"prefix":"10.1016","volume":"47","author":[{"given":"Mustafa","family":"Calik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Ciftci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Sarikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozcan","family":"Kocaturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Abuhandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Taskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Kandemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tah\u0131r Kurtulus","family":"Yoldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurten","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2015.04.039_bb0005","series-title":"Swaiman's pediatric neurology: principles and practice","first-page":"959","article-title":"Neurophysiology of seizures and epilepsy","author":"Stafstrom","year":"2012"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0010","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2174\/0929867320666131119154018","article-title":"Receptors of peptides as therapeutic targets in epilepsy research","volume":"21","author":"Dobolyi","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.npep.2013.10.015","article-title":"Neuropeptides in epilepsy","volume":"47","author":"Kovac","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0020","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/brain\/awh200","article-title":"Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood","volume":"127","author":"Arts","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.12.008","article-title":"Peripheral markers of blood\u2013brain barrier damage","volume":"342","author":"Marchi","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eplepsyres.2008.05.006","article-title":"Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video\u2013EEG study","volume":"81","author":"Palmio","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yebeh.2009.02.032","article-title":"Clinical MRI in children and adults with focal epilepsy: a critical review","volume":"15","author":"Woermann","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0887-8994(96)00006-9","article-title":"Breath-holding spells","volume":"14","author":"Breningstall","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00381-012-2001-8","article-title":"Increased oxidant status in children with breath-holding spells","volume":"29","author":"Calik","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0050","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1651-2227.2005.tb02080.x","article-title":"Autonomic nervous system functions in children with breath-holding spells and effects of iron deficiency","volume":"94","author":"Kolk\u0131ran","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ped.12090","article-title":"Breath holding spells: point prevalence and associated factors among Turkish children","volume":"55","author":"Carman","year":"2013","journal-title":"Pediatr Int"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/WNP.0000000000000020","article-title":"Breath-holding spells may be associated with maturational delay in myelination of brain stem","volume":"31","author":"Vurucu","year":"2014","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0065","first-page":"125","article-title":"Breath-holding spells in childhood","volume":"146","author":"DiMario","year":"1992","journal-title":"AJDC"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/peds.107.2.265","article-title":"Prospective study of children with cyanotic and pallid breath-holding spells","volume":"107","author":"DiMario","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0075","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5603\/CJ.2011.0040","article-title":"Permanent cardiac pacing in a 2.5month-old infant with severe cyanotic breath-holding spells and prolonged asystole","volume":"18","author":"Ergul","year":"2011","journal-title":"Cardiol J"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0080","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1046\/j.1471-4159.1997.69062294.x","article-title":"S100beta induces neuronal cell death through nitric oxide release from astrocytes","volume":"69","author":"Hu","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0085","first-page":"97","article-title":"The janus face of glial-derived S100B: beneficial and detrimental functions in the brain","volume":"21","author":"Van Eldik","year":"2003","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14767050903181468","article-title":"New markers of neonatal neurology","volume":"22","author":"Gazzolo","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/jemt.10303","article-title":"S100B in brain damage and neurodegeneration","volume":"60","author":"Rothermundt","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.seizure.2012.10.012","article-title":"Elevated serum S-100B levels in children with temporal lobe epilepsy","volume":"22","author":"Calik","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2377-9-51","article-title":"Oxidative stress and S-100B protein in children with bacterial meningitis","volume":"9","author":"Hamed","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0110","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12035-014-8669-x","article-title":"Neuropeptides as targets for the development of anticonvulsant drugs","volume":"50","author":"Clynen","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000345258.18071.54","article-title":"Neuropeptide Y: its multiple effects in the CNS and potential clinical significance","volume":"72","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2012.09.004","article-title":"Neuropeptide Y and its role in CNS disease and repair","volume":"238","author":"Decressac","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/adc.81.3.261","article-title":"Breath holding spells in 91 children and response to treatment with iron","volume":"3","author":"Mocan","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-3476(95)70456-6","article-title":"Resolution of breath-holding spells with treatment of concomitant anemia","volume":"126","author":"Colina","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3476(97)70237-3","article-title":"Effectiveness of iron therapy on breath-holding spells","volume":"130","author":"Daoud","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0140","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/adc.65.9.953","article-title":"Recurrent cyanotic episodes with severe arterial hypoxaemia and intrapulmonary shunting: a mechanism for sudden death","volume":"65","author":"Southall","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0145","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1373\/49.6.967","article-title":"Pediatric concentrations of S100B protein in blood: age- and sex-related changes","volume":"49","author":"Gazzolo","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2013.10.040","article-title":"Interictal serum S-100B protein levels in intractable epilepsy: a case\u2013control study","volume":"558","author":"Calik","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0920-1211(99)00026-1","article-title":"Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy","volume":"36","author":"Steinhoff","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2010.08.036","article-title":"Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case\u2013control study","volume":"484","author":"Lu","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2004.11.022","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model","volume":"1033","author":"Stroud","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0180","first-page":"461","article-title":"Inhibitory effect of neuropeptide y on epileptiform activity in the frontal cortex and hippocampus in vitro","volume":"47","author":"Bijak","year":"1995","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.43.s.5.13.x","article-title":"Antiepileptic actions of neuropeptide Y in the mouse hippocampus require Y5 receptors","volume":"43","author":"Baraban","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0190","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1152\/jn.1997.78.3.1651","article-title":"Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro","volume":"78","author":"Klapstein","year":"1997","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0195","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1460-9568.2007.05348.x","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors","volume":"25","author":"Morris","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0200","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1528-1167.2011.03370.x","article-title":"Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model","volume":"53","author":"Van Raay","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0205","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nm0797-761","article-title":"Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors","volume":"7","author":"Woldbye","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0215","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hipo.10110","article-title":"Neuropeptide Y delays hippocampal kindling in the rat","volume":"13","author":"Reibel","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(89)90234-5","article-title":"Hippocampal inter neuron loss and plasticity in human temporal lobe epilepsy","volume":"495","author":"de Lanerolle","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0230","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1523\/JNEUROSCI.21-15-05804.2001","article-title":"Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy","volume":"21","author":"Furtinger","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0235","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pediatrneurol.2014.05.001","article-title":"The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy","volume":"51","author":"Ozcelik","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0240","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.seizure.2013.07.007","article-title":"The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy","volume":"22","author":"Sonmez","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0245","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/08830738050200101501","article-title":"Serum insulin, leptin, and neuropeptide Y levels in epileptic children treated with valproate","volume":"20","author":"Aydin","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000327367","article-title":"Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate","volume":"76","author":"Cansu","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0255","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pediatrneurol.2012.08.003","article-title":"Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment","volume":"47","author":"Okuyaz","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0260","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/381415a0","article-title":"Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y","volume":"381","author":"Erickson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2004.04.006","article-title":"Neuropeptide Y, and epilepsy: recent progress, prospects and controversies","volume":"38","author":"Baraban","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/JMN:25:3:275","article-title":"Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold","volume":"25","author":"Dub\u00e9","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1607-551X(10)70002-4","article-title":"Lower plasma neuropeptide Y level in patients with atypical febrile convulsions","volume":"26","author":"Lin","year":"2010","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.yebeh.2015.04.039_bb0280","first-page":"246","article-title":"Lack of correlation between plasma neuropeptide Y and typical and atypical febrile seizures","volume":"51","author":"Mahyar","year":"2013","journal-title":"Acta Med Iran"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015002085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015002085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T14:00:25Z","timestamp":1566741625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505015002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":52,"alternative-id":["S1525505015002085"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.039","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of both serum S-100B protein and neuropeptide-Y levels in childhood breath-holding spells","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}